AI assistant
Sending…
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2020
Nov 20, 2020
32163_dirs_2020-11-20_0fe51c04-af49-48a7-b74c-e2d36bbb599c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2020-11-18
Reporting Person: Fleming Alison B (Chief Technology Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-11-18 | Common Stock | M | 16000 | $5.73 | Acquired | 117386 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-11-18 | Stock Option (Right to Purchase) | $5.73 | M | 16000 | Disposed | 2025-03-19 | Common Stock (16000) | Direct |
Footnotes
F1: The option was fully vested and exercisable as of November 18, 2020.
More from COLLEGIUM PHARMACEUTICAL, INC
Regulatory Filings
2026
May 15
Regulatory Filings
2026
May 12
Interim / Quarterly Report
2026
May 7
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Regulatory Filings
2026
Apr 7
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 20
Annual Report
2026
Feb 26